These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8187833)

  • 1. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
    Barth H; Kinzel V
    J Cell Physiol; 1995 Jan; 162(1):44-51. PubMed ID: 7814450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester.
    Barth H; Hoffmann I; Klein S; Kaszkin M; Richards J; Kinzel V
    J Cell Physiol; 1996 Sep; 168(3):589-99. PubMed ID: 8816913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation with 1 Gy prevents the activation of the mitotic inducers mitosis-promoting factor (MPF) and cdc25-C in HeLa cells.
    Barth H; Hoffmann I; Kinzel V
    Cancer Res; 1996 May; 56(10):2268-72. PubMed ID: 8625296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of protein phosphatase 2A activity in HeLa cells at the G2-mitosis transition and unscheduled reactivation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA).
    Klingler-Hoffmann M; Barth H; Richards J; König N; Kinzel V
    Eur J Cell Biol; 2005 Aug; 84(8):719-32. PubMed ID: 16180310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.
    Baratte B; Meijer L; Galaktionov K; Beach D
    Anticancer Res; 1992; 12(3):873-80. PubMed ID: 1320360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of MPF and histone H1 kinase activity differ during the G2- to M-phase transition in mouse oocytes.
    Jung T; Moor RM; Fulka J
    Int J Dev Biol; 1993 Dec; 37(4):595-600. PubMed ID: 8180003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From ovocyte to biochemistry of the cell cycle].
    Ozon R
    Verh K Acad Geneeskd Belg; 1991; 53(4):365-85. PubMed ID: 1659057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle.
    Gautier J; Matsukawa T; Nurse P; Maller J
    Nature; 1989 Jun; 339(6226):626-9. PubMed ID: 2543932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence.
    Jantzen H; Schulze I
    Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
    Lock RB
    Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates.
    Rialet V; Meijer L
    Anticancer Res; 1991; 11(4):1581-90. PubMed ID: 1660692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
    J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPF components and meiotic competence in growing pig oocytes.
    Christmann L; Jung T; Moor RM
    Mol Reprod Dev; 1994 May; 38(1):85-90. PubMed ID: 8049069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
    Eblen ST; Fautsch MP; Burnette RJ; Snyder M; Leof EB
    Cancer Res; 1995 May; 55(9):1994-2000. PubMed ID: 7728771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.
    Shen SC; Huang TS; Jee SH; Kuo ML
    Cell Growth Differ; 1998 Jan; 9(1):23-9. PubMed ID: 9438385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.
    Strausfeld U; Labbé JC; Fesquet D; Cavadore JC; Picard A; Sadhu K; Russell P; Dorée M
    Nature; 1991 May; 351(6323):242-5. PubMed ID: 1828290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.